Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2015-05-20 | New | $25,309,333 | $25,309,333 | Equity Only | 06b | SEC link |
| 2014-10-14 | New | $4,756,390 | $4,756,390 | Debt Only | 06b | SEC link |
| 2013-07-30 | Amended | $14,000,000 | $0 | Equity Only | 06 | SEC link |
| 2012-08-03 | New | $14,000,000 | $14,000,000 | Equity Only | 06 | SEC link |
| 2011-04-13 | Amended | $8,176,912 | $2,625,000 | Equity and Debt | 06 | SEC link |
| 2010-12-27 | New | $5,551,912 | $5,551,912 | Equity and Debt | 06 | SEC link |
| 2009-05-20 | New | $999,999 | Unknown | Equity Only | SEC link | |
| 2008-02-11 | Paper Filing | Unknown | Unknown | Other | Not Available |
| Name | Role |
|---|---|
| Scott Button | Director |
| Scott Cramer | Director |
| Laura G. King | Director, Executive |
| Fred T. Lee | Director |
| Fred T. Lee, Jr. | Director, Executive |
| Aaron Marshall | Executive |
| John Murphy | Director |
| Kirk Nielsen | Director |
| Luella Schmidt | Executive |
| Daniel Sullivan | Director, Executive |
| Daniel Joseph Sullivan Iii | Director, Executive |
| Daniel Van Der Weide | Director |
| Michael Wasserman | Director |